Anbio Biotechnology vs Alpha Teknova
NNNN and TKNO side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NNNN and TKNO compare
Alpha Teknova grew revenue faster over the last twelve months (15.4% versus 5.6% for Anbio Biotechnology).
Anbio Biotechnology keeps more of each dollar of sales as profit, with a net margin of 74.1% compared with −34.8% at Alpha Teknova.
Alpha Teknova scores higher on the StockData Score (12 against 11 for Anbio Biotechnology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NNNN | TKNO |
|---|---|---|
| Size and price | ||
| Market cap | – | $463M |
| Share price | $4.05 | $8.62 |
| Change, 1 year | −76.7% | 87.0% |
| Change, 5 years | – | −65.5% |
| Beta (5Y) | 1.58 | 1.19 |
| Employees | 27 | 158 |
| StockData Score | ||
| Total score | 11 | 12 (better) |
| Valuation score | 0 | 0 |
| Growth score | 1 | 3 (better) |
| Performance score | 5 (better) | 3 |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | – | 10.1× |
| P/B | – | 7.7× |
| FCF yield | – | −1.4% |
| Fair value | – | $3.45 |
| Margin of safety | – | −150% |
| Growth | ||
| Revenue growth (TTM) | 5.6% | 15.4% (better) |
| Revenue growth, 5Y average | – | 5.3% |
| Net income growth (TTM) | 170% | – |
| EPS growth (TTM) | 163% | – |
| Profitability | ||
| Gross margin | 87.2% (better) | 36.4% |
| Operating margin | 66.7% (better) | −32.7% |
| Net margin | 74.1% (better) | −34.8% |
| FCF margin | – | −13.9% |
| Return on equity | 27.0% (better) | −24.1% |
| Return on invested capital | 48.7% (better) | −25.3% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 344.31 (better) | 3.56 |
| Altman Z-score | – | 6.03 |
| Piotroski F-score | 5 | 6 (better) |
| Dividends and buybacks | ||
| Shareholder yield | – | 0.00% |
| Ownership | ||
| Held by institutions | – | 17.0% |
| Held by insiders | 0.00% | 1.3% |
| Insider net buying, 12 months | – | $144K |
| Short interest, % of float | 0.02% | 2.9% |
Go deeper
- NNNN stock overview
- NNNN income statement
- NNNN valuation and score
- TKNO stock overview
- TKNO income statement
- TKNO valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.